Perseo Pharma
Basel, CH · 1 known investors
Find your way into Perseo Pharma
Sign up to see every warm intro you have to Perseo Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Perseo Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Perseo Pharma is a biotech spin-off from the University of Applied Sciences in Basel, Switzerland, developing enzyme immobilization and bioconjugation technologies for therapeutic applications. The company focuses on creating novel platforms for drug delivery and enzyme-based therapies targeting inborn errors of metabolism and other rare diseases.
Founders & leadership
DY
Dr. Yves DudalCEO
PD

Prof. Dr. Patrick ShahgaldianCSO
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJan 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Perseo Pharma do?
- Perseo Pharma is a biotech spin-off from the University of Applied Sciences in Basel, Switzerland, developing enzyme immobilization and bioconjugation technologies for therapeutic applications. The company focuses on creating novel platforms for drug delivery and enzyme-based therapies targeting inborn errors of metabolism and other rare diseases.
- Who are Perseo Pharma's investors?
- Perseo Pharma's investors include 7G BioVentures.
- Where is Perseo Pharma headquartered?
- Perseo Pharma is headquartered in Basel, CH.